CAS: 956958-53-5 - N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide

Formula: C₂₁H₁₆N₆O₂S₂

InChI: InChI=1/C21H16N6O2S2/c1-13-6-9-15(10-7-13)31(28,29)27-21-20(23-16-4-2-3-5-17(16)24-21)22-14-8-11-18-19(12-14)26-30-25-18/h2-12H,1H3,(H,22,23)(H,24,27)

Synonyms:

• SC
• N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methylbenzenesulfonamide
• Pilaralisib
• Xl-147
• 3-Fluoro-5-formylbenzonitrile
• 3-Cyano-5-fluorobenzaldehyde
• N-(3-(benzo[c][1,2,5]thiadiazol-5-ylamino)quinoxalin-2-yl)-4-methylbenzenesulfonamide
• Benzonitrile, 3-fluoro-5-formyl-
• Xl147
• Sar245408

N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide

CAS: 956958-53-5

• Formula: C₂₁H₁₆N₆O₂S₂
• Purity: ≥98%
• Color and Shape: Solid
• Molecular weight: 448.5207

Pilaralisib analogue

CAS: 956958-53-5

Pilaralisib analogue (XL147 analogue) is a selective and reversible class I PI3K inhibitor for PI3Kα/δ/γ.

• Formula: C₂₁H₁₆N₆O₂S₂
• Purity: 99.72%
• Color and Shape: Solid
• Molecular weight: 448.52

N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methylbenzenesulfonamide,

CAS: 956958-53-5

N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methylbenzenesulfonamide is a drug that inhibits the activity of cyclin-dependent kinases CDK4/6 and is used …

• Formula: C₂₁H₁₆N₆O₂S₂
• Purity: Min. 95%
• Molecular weight: 448.52 g/mol